Aminoglycosides

Cards (38)

  • Who discovered the first aminoglycoside, Streptomycin, and in what year?
    Waksman in 1944
  • What are aminoglycosides primarily derived from?
    Actinomycetes
  • What suffix do aminoglycosides obtained from Streptomyces typically have?
    mycin
  • What suffix do aminoglycosides obtained from Micromonospora typically have?
    micin
  • What is the primary action of aminoglycosides on mRNA?
    They cause misreading of mRNA, leading to incorrect protein synthesis.
  • What is the chemical structure of aminoglycosides characterized by?
    Two aminosugars joined to one aminocyclitol moiety by glycosidic bonds.
  • What is the aminocyclitol moiety commonly found in most aminoglycosides?
    1. 2- Deoxystreptamine
  • What is the aminocyclitol in Streptomycin?
    Streptidine
  • What are the physicochemical properties of aminoglycosides?
    They are highly polar, water-soluble, and more active in alkaline pH.
  • How do aminoglycosides enter bacterial cells?
    Through passive diffusion and active transport mechanisms.
  • What is the mechanism of action of aminoglycosides related to the ribosomal subunit?
    They bind to the 30S ribosomal subunit and induce misreading of the genetic code on mRNA.
  • What is the result of the misreading induced by aminoglycosides?
    Wrong amino acids are incorporated into the peptide chain, eventually destroying peptide formation.
  • What does the term "bactericidal" mean in the context of aminoglycosides?
    It means their effect is dose-dependent and leads to bacterial cell death.
  • What are the two types of resistance mechanisms to aminoglycosides?
    1. Acquired (via plasmids or chromosomal changes)
    2. Natural (inherent)
  • What is one way bacteria can acquire resistance to aminoglycosides?
    By altering the bacterial outer surface to decrease drug penetration.
  • What is a natural resistance mechanism of anaerobes to aminoglycosides?
    They lack the energy-dependent transport mechanism that concentrates the drug in the bacterial cell.
  • How is aminoglycoside absorption when given orally?
    Extremely poor
  • What happens to aminoglycosides when given intramuscularly?
    They are rapidly absorbed and reach therapeutic levels in circulation within 2-1 hours.
  • Why do aminoglycosides have minimal distribution inside cells?
    Because they are highly polar compounds and insoluble in lipids.
  • Where do aminoglycosides have exceptional affinity in the body?
    Renal cortex tissue
  • What is the primary route of elimination for aminoglycosides?
    Renal elimination, primarily unchanged through glomerular filtration.
  • What is the half-life (T½) of most aminoglycosides?
    1. 3 hours
  • What is the half-life (T½) of Streptomycin?
    About 5 hours
  • What is the antimicrobial spectrum of aminoglycosides?
    • Mainly used to treat Gram-negative infections
    • Some Gram-positive bacteria are also affected
  • What is the clinical use of Streptomycin?
    It is used to treat mycobacterial infections such as tuberculosis (TB) and leptospirosis.
  • Why is Neomycin used topically?
    Because it is toxic when used systemically.
  • What is the clinical use of Gentamicin?

    It is used to treat severe Gram-negative infections resistant to common drugs.
  • What makes Amikacin a good alternative to Gentamicin?
    It is resistant to aminoglycosidases.
  • What is the clinical use of Tobramycin?
    It is similar to Gentamicin in its uses.
  • What is the significance of Netilmicin in clinical use?
    It may work in situations where bacteria are resistant to Gentamicin and Tobramycin.
  • What are the main toxicities associated with aminoglycosides?
    1. Ototoxicity
    2. Nephrotoxicity
    3. Neuromuscular blockade(curare-like effect)
    4. Hypersensitivity (rarely seen)
  • What does a small therapeutic index (TI) indicate about aminoglycosides?
    It indicates that toxicity can easily manifest.
  • How does ototoxicity occur with aminoglycosides?
    Drug accumulation in the ear leads to selective destruction of hearing receptors, causing tinnitus and deafness.
  • What is nephrotoxicity in the context of aminoglycosides?
    It is the accumulation of the drug in proximal tubule cells leading to renal impairment, which is reversible upon withdrawal.
  • What should be monitored during aminoglycoside treatment to prevent nephrotoxicity?
    Drug serum levels
  • What is the effect of aminoglycosides on neuromuscular function?
    They can cause a blockade leading to transient paralysis of skeletal muscles.
  • Who are individuals at risk for neuromuscular blockade when using aminoglycosides?
    Patients with myasthenia gravis and those given neuromuscular blockers during surgery.
  • How can neuromuscular blockade caused by aminoglycosides be reversed?
    By calcium replacement therapy.